Avacta Group (LON:AVCT) Sets New 52-Week Low – Here’s What Happened

Shares of Avacta Group Plc (LON:AVCT) reached a new 52-week low during trading on Tuesday . The company traded as low as GBX 39.25 ($0.50) and last traded at GBX 39.37 ($0.50), with a volume of 2737993 shares. The stock had previously closed at GBX 41.60 ($0.52).

Avacta Group Trading Down 5.4 %

The company has a debt-to-equity ratio of 52.53, a quick ratio of 4.96 and a current ratio of 1.29. The firm has a market cap of £149.55 million, a PE ratio of -5.07 and a beta of 1.12. The stock’s 50 day simple moving average is GBX 48.50 and its 200 day simple moving average is GBX 55.17.

Avacta Group Company Profile

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).